Viskase Holdings, Inc.

VISK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $7.9M $28.6M $9.2M $43.3M $44.3M $45.0M $46.9M $46.6M
Accounts Receivable $67.4M $62.8M $60.2M — — — — —
Inventory $105.3M $98.8M $96.8M — — — — —
Total Current Assets $227.3M $234.6M $208.6M $43.7M $44.7M $45.5M $47.2M $47.0M
Property, Plant & Equipment $147.7M $143.0M $141.3M — — — — —
Goodwill $3.0M $3.1M $3.1M — — — — —
Intangible Assets (Excl. Goodwill) $12.6M $12.9M $13.4M — — — — —
Total Assets $424.5M $428.9M $402.1M $43.7M $44.8M $45.5M $47.2M $47.3M
Liabilities
Accounts Payable $39.4M $36.9M $44.3M $331.0K $331.0K $331.0K $331.0K $331.0K
Total Current Liabilities $123.6M $116.9M $214.5M $540.0K $803.0K $554.0K $1.7M $438.0K
Long-Term Debt $74.9M $79.7M $141.8M — — — — —
Total Liabilities $237.7M $236.7M $256.3M $44.6M $44.3M $43.6M $44.2M $44.5M
Stockholders' Equity
Retained Earnings $-23.6M $-18.6M $-11.9M $-72.2M $-71.4M $-70.4M $-69.9M $-69.8M
Total Stockholders' Equity $186.8M $192.2M $145.8M $-923.0K $432.0K $2.0M $3.0M $2.8M
← Newer Page 1 of 8 Older →